These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 9579853)

  • 1. New developments in cancer treatment with the novel thymidylate synthase inhibitor raltitrexed ('Tomudex').
    Blackledge G
    Br J Cancer; 1998; 77 Suppl 2(Suppl 2):29-37. PubMed ID: 9579853
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mature results from three large controlled studies with raltitrexed ('Tomudex').
    Cunningham D
    Br J Cancer; 1998; 77 Suppl 2(Suppl 2):15-21. PubMed ID: 9579851
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and tolerability of a new inhibitor of thymidylate synthase: 'Tomudex' (raltitrexed).
    Cunningham D
    Tumori; 1997; 83(1 Suppl):S70-1. PubMed ID: 9154074
    [No Abstract]   [Full Text] [Related]  

  • 4. Future developments with 'Tomudex' (raltitrexed).
    Van Cutsem E
    Anticancer Drugs; 1997 Aug; 8 Suppl 2():S33-8. PubMed ID: 9376636
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 'Tomudex' (ZD1694): a novel thymidylate synthase inhibitor with clinical antitumour activity in a range of solid tumours. 'Tomudex' International Study Group.
    Cunningham D; Zalcberg J; Smith I; Gore M; Pazdur R; Burris H; Meropol NJ; Kennealey G; Seymour L
    Ann Oncol; 1996 Feb; 7(2):179-82. PubMed ID: 8777175
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phase II study of raltitrexed (Tomudex) in chemotherapy-pretreated patients with advanced colorectal cancer. Tomudex Cooperative Study Group.
    Sato A; Kurihara M; Horikoshi N; Aiba K; Kikkawa N; Shirouzu K; Mitachi Y; Sakata Y; Wakui A
    Anticancer Drugs; 1999 Sep; 10(8):741-8. PubMed ID: 10573207
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Raltitrexed: current clinical status and future directions.
    Van Cutsem E; Cunningham D; Maroun J; Cervantes A; Glimelius B
    Ann Oncol; 2002 Apr; 13(4):513-22. PubMed ID: 12056700
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Raltitrexed (Tomudex) in combination with platinum-based agents and/or anthracyclines: preliminary results of phase I clinical trials.
    Armand JP; Seymour L; Evans TR
    Eur J Cancer; 1999 Mar; 35 Suppl 1():S14-8. PubMed ID: 10645209
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 'Tomudex' (raltitrexed) development: preclinical, phase I and II studies.
    Judson IR
    Anticancer Drugs; 1997 Aug; 8 Suppl 2():S5-9. PubMed ID: 9376637
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Raltitrexed in colorectal cancer].
    Comandone A; Oliva C; Dal Canton O; Boglione A; Bergnolo P
    Tumori; 2001; 87(1 Suppl 1):S53-4. PubMed ID: 11300026
    [No Abstract]   [Full Text] [Related]  

  • 11. Raltitrexed. A review of its pharmacological properties and clinical efficacy in the management of advanced colorectal cancer.
    Gunasekara NS; Faulds D
    Drugs; 1998 Mar; 55(3):423-35. PubMed ID: 9530547
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Measuring quality of life: impact of chemotherapy for advanced colorectal cancer. Experience from two recent large phase III trials.
    Anderson H; Palmer MK
    Br J Cancer; 1998; 77 Suppl 2(Suppl 2):9-14. PubMed ID: 9579850
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phase II trial of raltitrexed ('Tomudex') in advanced small-cell lung cancer.
    Woll PJ; Basser R; Le Chevalier T; Drings P; Perez Manga G; Adenis A; Seymour L; Smith F; Thatcher N
    Br J Cancer; 1997; 76(2):264-5. PubMed ID: 9231930
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overview of the tolerability of 'Tomudex' (raltitrexed): collective clinical experience in advanced colorectal cancer.
    Zalcberg J
    Anticancer Drugs; 1997 Aug; 8 Suppl 2():S17-22. PubMed ID: 9376633
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical efficacy of 'Tomudex' (raltitrexed) in advanced colorectal cancer.
    Kerr DJ
    Anticancer Drugs; 1997 Aug; 8 Suppl 2():S11-5. PubMed ID: 9376632
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting thymidylate synthase in colorectal cancer: critical re-evaluation and emerging therapeutic role of raltitrexed.
    Avallone A; Di Gennaro E; Silvestro L; Iaffaioli VR; Budillon A
    Expert Opin Drug Saf; 2014 Jan; 13(1):113-29. PubMed ID: 24093908
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The use of raltitrexed (tomudex) in a patient with 5-fluorouracil induced myocardial ischaemia.
    Nutting C; Folkes A
    Clin Oncol (R Coll Radiol); 1999; 11(1):66. PubMed ID: 10194593
    [No Abstract]   [Full Text] [Related]  

  • 18. Open, randomized, multicenter trial of raltitrexed versus fluorouracil plus high-dose leucovorin in patients with advanced colorectal cancer. Tomudex Colorectal Cancer Study Group.
    Cocconi G; Cunningham D; Van Cutsem E; Francois E; Gustavsson B; van Hazel G; Kerr D; Possinger K; Hietschold SM
    J Clin Oncol; 1998 Sep; 16(9):2943-52. PubMed ID: 9738562
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Raltitrexed (tomudex) administration in patients failing multiple prior chemotherapy regimens in advanced colorectal cancer: a pilot study.
    Tsavaris N; Kosmas C; Vadiaka M; Kontos A; Fotia M; Angelopoulou A; Vrizidis N; Soulla M; Sougioultzis S; Koufos Ch
    Invest New Drugs; 2002 Feb; 20(1):133-6. PubMed ID: 12003191
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Raltitrexed (Tomudex) in combination treatment for colorectal cancer: new perspectives.
    Van Cutsem E
    Eur J Cancer; 1999 Mar; 35 Suppl 1():S1-2. PubMed ID: 10645206
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.